VistaGen Therapeutics (VTGN) Earnings Date & Reports

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTGN is expected to report earnings to rise 25.00% to -37 cents per share on November 05

VistaGen Therapeutics VTGN Stock Earnings Reports

Q3'26

Est.

$-0.37

Q2'26

Missed

by $0.05

Q4'25

Beat

by $0.28

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.14

The last earnings report on August 14 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 3.02M shares outstanding, the current market capitalization sits at 13.09M.

View a ticker or compare two or three

VTGN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for VTGN